This legal opinion confirms the approval and authorization for the reserved grant of restricted stock under Ruizhi Pharmaceutical's 2025 incentive plan. The company will grant 6 million shares to 19 eligible participants on May 28, 2026. The opinion asserts that all conditions and legal requirements have been met, ensuring compliance with relevant laws and regulations.
Summary generated by AI · Always verify with source document
Beijing Jingtian & Gongcheng Law Firm Shanghai Office has accepted the commission from Ruizhi Pharmaceutical and, in accordance with the provisions of the Company Law, Securities Law, Management Measures, and other relevant laws, regulations, and normative documents, has issued the following legal opinions regarding the company's incentive plan:
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.